Tianjin Zhong Xin Pharmaceutical Group says Jinhushen Biological Medical Science and Technology has completed its acquisition in its controlling shareholder, Tianjin Pharmaceutical Holdings (TPH) on March 26. Jinhushen, on Dec 19, 2020, entered into a sale and purchase agreement (SPA) with Tianjin B...

FOLLOWING a transfer of a two-thirds ownership in Chinese conglomerate Tianjin Pharmaceutical Holdings (TPH) to a third party, a "chain offer" for the remaining shares of Tianjin Zhong Xin Pharmaceutical Group on both the Singapore and Shanghai bourses that are not held by offeror ...

Tianjin Zhong Xin Pharmaceutical Group announced on Dec 20 that Jinhushen Biological Medical Science and Technology has acquired a 67% stake in its controlling shareholder, Tianjin Pharmaceutical Holdings (TPH). See: Tianjin Zhong Xin Pharmaceutical triggers SGX query as shares increase by over...

TIANJIN Zhong Xin Pharmaceutical Group announced on Sunday that Jinhushen Biological Medical Science and Technology will be acquiring a 67 per cent stake in its controlling shareholder Tianjin Pharmaceutical Holdings for an undisclosed sum.